- Home
- AIRE vs OPTN Comparison
AIRE vs OPTN Comparison
Compare AIRE & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- OPTN
- Stock Information
- Founded
- AIRE 2021
- OPTN 2010
- Country
- AIRE United States
- OPTN United States
- Employees
- AIRE N/A
- OPTN N/A
- Industry
- AIRE
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- OPTN Health Care
- Exchange
- AIRE Nasdaq
- OPTN Nasdaq
- Market Cap
- AIRE 86.1M
- OPTN 92.8M
- IPO Year
- AIRE N/A
- OPTN 2017
- Fundamental
- Price
- AIRE $0.65
- OPTN $9.28
- Analyst Decision
- AIRE Strong Buy
- OPTN Hold
- Analyst Count
- AIRE 1
- OPTN 3
- Target Price
- AIRE $3.00
- OPTN $9.00
- AVG Volume (30 Days)
- AIRE 252.6K
- OPTN 106.0K
- Earning Date
- AIRE 05-23-2025
- OPTN 05-13-2025
- Dividend Yield
- AIRE N/A
- OPTN N/A
- EPS Growth
- AIRE N/A
- OPTN N/A
- EPS
- AIRE N/A
- OPTN N/A
- Revenue
- AIRE $948,420.00
- OPTN $78,226,000.00
- Revenue This Year
- AIRE $206.83
- OPTN $30.49
- Revenue Next Year
- AIRE $158.08
- OPTN $13.51
- P/E Ratio
- AIRE N/A
- OPTN N/A
- Revenue Growth
- AIRE 419.58
- OPTN 10.20
- 52 Week Low
- AIRE $0.52
- OPTN $4.82
- 52 Week High
- AIRE $4.49
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- AIRE 33.13
- OPTN 78.46
- Support Level
- AIRE $0.60
- OPTN $9.14
- Resistance Level
- AIRE $0.85
- OPTN $9.30
- Average True Range (ATR)
- AIRE 0.07
- OPTN 0.14
- MACD
- AIRE 0.02
- OPTN -0.10
- Stochastic Oscillator
- AIRE 40.27
- OPTN 96.36
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.